Prokidney (PROK) Total Current Liabilities (2021 - 2026)
Prokidney's (PROK) quarterly Total Current Liabilities came in at $25.9 million in Q1 2026, down 20.96% year-on-year from $32.8 million in Q1 2025, and down 15.65% on a QoQ basis from $30.7 million in Q4 2025.
Prokidney (PROK) Total Current Liabilities (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Total Current Liabilities data on file, last reported at $25.9 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 20.96% year-over-year to $25.9 million in Q1 2026; TTM through Mar 2026 was $25.9 million, a 20.96% decrease from a year earlier, with the FY2025 full-year figure at $30.7 million, down 15.12% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $25.9 million, down from $30.7 million in the prior quarter.
- Over the last five years, Total Current Liabilities for PROK reached as high as $36.2 million in Q4 2024 and fell as low as $5.4 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $21.4 million across 5 years, with a median of $24.5 million in 2023.
- Across the five-year window, Total Current Liabilities soared 17747.95% in 2022 and fell 20.96% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $10.9 million in 2022, then soared by 130.28% to $25.0 million in 2023, then soared by 44.65% to $36.2 million in 2024, then retreated by 15.12% to $30.7 million in 2025, then retreated by 15.65% to $25.9 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $25.9 million in Q1 2026, $30.7 million in Q4 2025, and $29.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 66.94 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 13.42 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.81 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 289.60 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | 25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.93 Mn |
| Dec 31, 2025 | 30.74 Mn |
| Sep 30, 2025 | 29.06 Mn |
| Jun 30, 2025 | 28.26 Mn |
| Mar 31, 2025 | 32.81 Mn |
| Dec 31, 2024 | 36.22 Mn |
| Sep 30, 2024 | 25.18 Mn |
| Jun 30, 2024 | 20.59 Mn |
| Mar 31, 2024 | 19.30 Mn |
| Dec 31, 2023 | 25.04 Mn |
| Sep 30, 2023 | 20.99 Mn |
| Jun 30, 2023 | 24.50 Mn |
| Mar 31, 2023 | 11.28 Mn |
| Dec 31, 2022 | 10.87 Mn |
| Sep 30, 2022 | 9.84 Mn |
| Jun 30, 2022 | 7.93 Mn |
| Mar 31, 2022 | 5.41 Mn |
| Dec 31, 2021 | 12.31 Mn |
| Sep 30, 2021 | 55,138.00 |
| Jun 30, 2021 | 603,129.00 |